SECTORAL ASSET MANAGEMENT INC - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 191 filers reported holding ASCENDIS PHARMA A/S in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.7%.

Quarter-by-quarter ownership
SECTORAL ASSET MANAGEMENT INC ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$397,127
+59.1%
4,241
+51.7%
0.08%
+83.3%
Q2 2023$249,543
+37.7%
2,796
+65.4%
0.04%
+20.0%
Q1 2023$181,202
-12.2%
1,6900.0%0.04%
-12.5%
Q4 2022$206,400
+5.8%
1,690
-10.6%
0.04%
+5.3%
Q3 2022$195,000
+10.8%
1,8900.0%0.04%
+8.6%
Q2 2022$176,000
-75.5%
1,890
-69.2%
0.04%
-72.7%
Q1 2022$719,000
-12.8%
6,1290.0%0.13%
+3.2%
Q4 2021$825,000
-86.6%
6,129
-84.1%
0.12%
-75.8%
Q3 2021$6,160,000
+1219.1%
38,650
+988.7%
0.51%
+1247.4%
Q2 2021$467,000
+11.5%
3,550
+9.2%
0.04%
+18.8%
Q1 2021$419,000
-27.4%
3,250
-89.5%
0.03%
+14.3%
Q1 2016$577,000
+1.2%
31,1000.0%0.03%
+16.7%
Q4 2015$570,000
+3.6%
31,1000.0%0.02%
-4.0%
Q3 2015$550,000
-86.8%
31,100
-86.8%
0.02%
-85.6%
Q2 2015$4,165,000
-67.2%
235,560
-67.8%
0.17%
-63.9%
Q1 2015$12,694,000731,6600.48%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q4 2022
NameSharesValueWeighting ↓
RA Capital Management 5,865,338$978,221,00013.68%
Vivo Capital, LLC 1,797,745$299,828,00013.38%
Sofinnova Investments, Inc. 1,109,874$185,105,00011.02%
Avoro Capital Advisors LLC 1,800,000$300,204,0005.17%
Eventide Asset Management 1,704,148$284,218,0004.36%
Stenahm Asset Managment Ltd 29,000$4,837,0004.07%
Ghost Tree Capital, LLC 105,000$17,512,0003.90%
Eversept Partners, LP 187,043$31,195,0323.66%
Spyglass Capital Management LLC 701,594$117,012,0003.59%
Q Global Advisors, LLC 23,183$3,866,0002.72%
View complete list of ASCENDIS PHARMA A/S shareholders